3
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Maintenance of Duodenal Ulcer Healing by Antacids

Pages 54-59 | Published online: 08 Jul 2009

References

  • Heading RC. Antacids and duodenal ulcer. Gut 1984; 25: 1195–1198
  • Peterson W L, Sturdevant R AL, Frankl H D, et al. Healing of duodenal ulcer with an antacid regimen. N Engl J Med 1977; 297: 341–345
  • Berstad A, Weberg R. Antacids in the treatment of gastroduodenal ulcer. Scand J Gastroenterol 1986; 21: 385–391
  • Miller J P, Faragher EB. Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?. Br Med J 1986; 293: 1117–1118
  • Gough K R, Korman M G, Bardhan K D, Crowe J P, Reed P I, Smith RN. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. Lancet 1984; 2: 659–662
  • Silvis SE. Final report on the United States multi-center trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer. J Clin Gastroenterol 1985; 7: 482–487
  • Takemoto T, Kimura K, Okita K, et al. Efficacy of sucralfate in the prevention of recurrence of peptic ulcer–double blind multicenter study with cimetidine. Scand J Gastroenterol 1987; 22: 49–60, suppl 140
  • Cayer D, Sohmer M F, Ruffin JM. The effect of prolonged continuous therapy on the course of chronic recurring peptic ulcer. NC Med J 1957; 18: 315–317
  • Bianchi Porro G, Lazzaroni M, Pace F, Petrillo M. Long-term low-dose antacid versus cimetidine therapy in the treatment of duodenal ulcer recurrence. Scand J Gastroenterol 1986; 21: 1144–1146
  • Bardhan KD. Are antacids as effective as cimetidine in preventing duodenal ulcer relapse?. Gastroenterology 1986; 90: 1336
  • Miller JP. Antacids can prevent duodenal ulcer relapse. Proceedings of the World Congresses of Gastroenterology. São PauloBrazil 1986
  • Bardhan K D, Hunter J O, Miller J P, et al. Antacid maintenance therapy in the prevention of duodenal ulcer relapse. Gut, (in press)
  • Bianchi Porro G, Petrillo M, Lazzaroni M, San-Galetti O. The longer-term treatment of duodenal ulceration with cimetidine. Peptic ulcer disease, advances in pathogenesis and treatment, G Bianchi Porro, KD Bardhan. Cortina International, Verona 1982; 107–113
  • Sontag S, Graham D Y, Belsito A, et al. Cimetidine, cigarette smoking and recurrence of duodenal ulcer. N Engl J Med 1984; 311: 689–693
  • Holtermuller K-H, Konig U. Safety of antacids. Antacids in peptic ulcer disease: state of the art, G Bianchi Porro, CT Richardson. Cortina International, Verona 1988; 41–52
  • Rune S J, Bendtsen F. Effect of antacids on gastric and duodenal bulb acidity. Antacids in peptic ulcer disease: state of the art, G Bianchi Porro, CT Richardson. Cortina International, Verona 1988; 17–29
  • Deering T B, Malagelada J-R. Comparison of an H2-receptor antagonist and a neutralising antacid on postprandial acid delivery into the duodenum in patients with duodenal ulcer. Gastroenterology 1977; 73: 11–14
  • Domschke W, Hagel J, Ruppin H, Kaduk B. Antacids and gastric mucosal protection. Scand J Gastroenterol 1986; 21: 144–149, suppl 125
  • Ruppin H. Antacids in peptic ulcer disease–effect on prostaglandin synthesis and gastric mucosal barrier. Antacids in peptic ulcer disease: state of the art, G Bianchi Porro, CT Richardson. Cortina International, Verona 1988; 25–29
  • Marshall B J, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311–1314
  • Dooley C P, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med 1988; 108: 70–79
  • Miller J P, Faragher EB. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease. Scand J Gastroenterol 1989; 24: 39–45, suppl 160
  • Berstad A, Alexander B, Weberg R, Serck-Hanssen A, Holland S, Hirschowitz BI. Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes. Gastroenterology 1988; 95: 619–624
  • Boyd E JS, Penston J G, Johnston D A, Wormsley KG. Does maintenance therapy keep duodenal ulcers healed?. Lancet 1988; 1: 1324–1327
  • Elashoff J D, Koch G G, Chi G YH. Designing a clinical trial to demonstrate prevention of ulcer recurrence: modelling simulation approaches. Statist Med 1988; 7: 877–888

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.